When was Ceresti founded?

Ceresti was founded in 2013 and raised its 1st funding round 5 years after it was founded.

Where is Ceresti located?

Ceresti is headquartered in Carlsbad, United States.

How many employees does Ceresti have?

As of Jun 30, 2026, the latest employee count at Ceresti is 70.

Is Ceresti a funded company?

Ceresti is a funded company, having raised a total of $36.1M across 8 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Jul 19, 2018.

When was the latest funding round of Ceresti?

Ceresti's latest funding was a $***** Series B round on May 01, 2026, with participation from 0 investor.

Where does Ceresti rank among its competitors?

Ceresti ranks 1st amongst 140 active competitors, of which 15 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Ceresti, which secured $10M in May, 2026.

Who are the top competitors of Ceresti?

Ceresti's top competitors include Aqtual, Evergreen Nephrology and AdaptX. Among them, Ceresti secured the most recent funding round in May, 2026.

Ceresti - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.ceresti.com/
Social
Email ID: *****@ceresti.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

Carlsbad, United States

Stage

Series B

Total Funding

$36.1M in 8 rounds

Latest Funding Round

Series B, May 01, 2026, $*****

Investors

Prairie Ventures & 5 more

Ranked

1^st among 140 active competitors

Employee Count

70 as on Jun 30, 2026

Similar Companies

Aqtual & 148 more

View Ceresti's full profile

Ceresti has raised a total funding of $36.1M over 8 rounds. Its first funding round was on Jul 19, 2018. Ceresti has 6 institutional investors.

Here is the list of recent funding rounds of Ceresti:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2026	5578821	Series B	3097762	7657154	9003068	6105256
Jul 31, 2025	7206701	Series B	5756763	9343261	8232693	1184243
Feb 07, 2025	5023338	Series A	2727509	6083075	1418620	7193229

Access funding benchmarks and valuations. Sign up today!

View details of Ceresti's funding rounds and investors

The founders of Ceresti is Dirk Soenksen.

Here are the details of Ceresti's key team members:

Dirk Soenksen: Co-Founder & CEO of Ceresti.

View details of Ceresti's Founder profiles and Board Members

Ceresti's employee count trend

Ceresti has 70 employees as of Jun 26. Here is Ceresti's employee count trend over the years:

Uncover Ceresti's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ceresti include Aqtual, Evergreen Nephrology and AdaptX. Here is the list of Top 10 competitors of Ceresti, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceresti 2013, Carlsbad (United States), Series B	Provider of chronic care management and monitoring solutions	$36.1M	Prairie Ventures, UCSF Rosenman Institute ... & 4 others	49/100
2nd	Aqtual 2017, San Francisco (United States), Series B	Provider of clinical product launching, chronic disease solution, and diagnostic platform services	$47M	Genoa Ventures, Manta Ray Ventures & 3 others	49/100
3rd	Evergreen Nephrology 2021, Nashville (United States), Series D	Provider of chronic care management services for kidney diseases	$130M	Oak HC/FT, Rubicon Founders & 3 others	43/100
4th	AdaptX 2016, Seattle (United States), Series A	Provider of clinical management solutions	$24.1M	Cercano Management, Arnold Venture Group & 8 others	42/100
5th	Tria Health 2009, Overland Park (United States), Unfunded	Provider of chronic care management services	-	-	38/100
6th	HealthNEXT 2008, Philadelphia (United States), Acquired	Provider of patient management solutions	$200K	Archetype	36/100
7th	Future Cardia 2021, Houston (United States), Series A	Provider of chronic care management services	$5M	La Jolla Holding, Empire Group International	36/100
8th	Pathalys 2021, Raleigh (United States), Series B	Provider of CKD biotherapeutics development services	$105M	TCG Crossover, Abingworth & 9 others	34/100
9th	Brown & Toland 1992, Oakland (United States), Acquired	Provider of healthcare technology and chronic care management services	-	-	34/100
10th	NYAM 1847, United States, Funding Raised	Provider of chronic care services	-	HHS, Imls & 3 others	34/100